62 related articles for article (PubMed ID: 7907833)
1. Localization and effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in human penile erectile tissue.
Hedlund P; Alm P; Hedlund H; Larsson B; Andersson KE
Acta Physiol Scand; 1994 Jan; 150(1):103-4. PubMed ID: 7907833
[No Abstract] [Full Text] [Related]
2. Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.
Hedlund P; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Hedlund H; Larsson B; Andersson KE
Br J Pharmacol; 1995 Oct; 116(4):2258-66. PubMed ID: 8564257
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
[TBL] [Abstract][Full Text] [Related]
4. Multiple receptors for PACAP and VIP.
Harmar T; Lutz E
Trends Pharmacol Sci; 1994 Apr; 15(4):97-9. PubMed ID: 7912462
[No Abstract] [Full Text] [Related]
5. Pituitary adenylate cyclase-activating polypeptide directly stimulates LH and FSH secretion by human pituitary gonadotrophinomas.
Petersen B; Buchfelder M; Fahlbusch R; Adams EF
Exp Clin Endocrinol Diabetes; 1996; 104(3):250-5. PubMed ID: 8817243
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
Cavallaro S; Copani A; D'Agata V; Musco S; Petralia S; Ventra C; Stivala F; Travali S; Canonico PL
Mol Pharmacol; 1996 Jul; 50(1):60-6. PubMed ID: 8700120
[TBL] [Abstract][Full Text] [Related]
7. Recognition of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide (PACAP/VIP) hybrids and related peptides by rat brain membranes.
Ando E; Nokihara K; Naruse S; Wray V
Biomed Pept Proteins Nucleic Acids; 1996; 2(2):41-6. PubMed ID: 9346825
[TBL] [Abstract][Full Text] [Related]
8. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
9. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
[TBL] [Abstract][Full Text] [Related]
10. PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus.
Nakata M; Kohno D; Shintani N; Nemoto Y; Hashimoto H; Baba A; Yada T
Neurosci Lett; 2004 Nov; 370(2-3):252-6. PubMed ID: 15488333
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
Delgado M; Jonakait GM; Ganea D
Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
[TBL] [Abstract][Full Text] [Related]
12. Effects of pituitary adenylate cyclase-activating polypeptide on facial nerve recovery in the Guinea pig.
Kimura H; Kawatani M; Ito E; Ishikawa K
Laryngoscope; 2003 Jun; 113(6):1000-6. PubMed ID: 12782812
[TBL] [Abstract][Full Text] [Related]
13. [Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice].
Takeda N; Murozono M; Watanabe S; Isshiki A; Watanabe Y
Masui; 2005 Mar; 54(3):240-8. PubMed ID: 15794099
[TBL] [Abstract][Full Text] [Related]
14. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylate cyclase activating polypeptide reduces A-type K+ currents and caspase activity in cultured adult mouse olfactory neurons.
Han P; Lucero MT
Neuroscience; 2005; 134(3):745-56. PubMed ID: 16019148
[TBL] [Abstract][Full Text] [Related]
16. Are vasoactive neuropeptide autoimmune fatigue-related disorders mediated via G protein-coupled receptors?
Staines D
Med Hypotheses; 2005; 65(1):29-31. PubMed ID: 15893112
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor.
Ogi K; Miyamoto Y; Masuda Y; Habata Y; Hosoya M; Ohtaki T; Masuo Y; Onda H; Fujino M
Biochem Biophys Res Commun; 1993 Nov; 196(3):1511-21. PubMed ID: 7902709
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase-activating peptide as a neurotransmitter in the canine ileal circular muscle.
Fox-Threlkeld JA; McDonald TJ; Woskowska Z; Iesaki K; Daniel EE
J Pharmacol Exp Ther; 1999 Jul; 290(1):66-75. PubMed ID: 10381761
[TBL] [Abstract][Full Text] [Related]
19. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice.
Ohtaki H; Dohi K; Yofu S; Nakamachi T; Kudo Y; Endo S; Aruga T; Goto N; Watanabe J; Kikuyama S; Shioda S
Regul Pept; 2004 Dec; 123(1-3):61-7. PubMed ID: 15518894
[TBL] [Abstract][Full Text] [Related]
20. Expression of mRNAs for PACAP and its receptor in human neuroblastomas and their relationship to catecholamine synthesis.
Isobe K; Kaneko M; Kaneko S; Nissato S; Nanmoku T; Takekoshi K; Okuda Y; Kawakami Y
Regul Pept; 2004 Dec; 123(1-3):29-32. PubMed ID: 15518890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
